Fundraising FoxDistributed Network Advisors
Venture capitalPre-Seed–Seed
Find your way into Distributed Network Advisors
Sign up to see every warm intro you have to Distributed Network Advisors
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Distributed Network Advisors team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
DNA Fund applies a systematic, data-driven investment approach that draws on macroeconomic insights and asset class-specific data to identify asymmetric opportunities and guide positioning. Its offerings span the maturing crypto asset class, from liquid token funds benchmarked to Bitcoin, to market-neutral strategies aiming for consistent returns above treasury yields, to specialized vehicles focused on AI and early-stage innovation. Each fund carries a distinct mandate so investors can align capital with strategies matching their return objectives and risk tolerance, pursuing strong risk-adjusted performance across market cycles.
Source: firm website, verified Oct 2, 2026.
Frequently asked questions
- What stage does Distributed Network Advisors invest at?
- Distributed Network Advisors invests at the Pre-Seed, Seed stages.
- What sectors does Distributed Network Advisors focus on?
- Distributed Network Advisors focuses on AI & Machine Learning, Crypto & Web3.
Images
Similar investors
August Capital is a venture capital firm that invests in a small number of companies, providing hands-on support to entrepreneurs building their businesses.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Blueyard is a small equal partnership with offices in the US and Europe, investing in early-stage companies.
Breyer Capital is an early-stage, high-conviction investment firm with a dedicated healthcare and life sciences practice backing founders rebuilding medicine at the intersection of science, data, care delivery, and economics.
Cherubic Ventures is known for investing before a startup even launches or reaches product-market fit, often as the first institutional investor, while also setting aside half of its latest fund for follow-on support all the way through pre-IPO; it was also one of the first venture firms to operate as a solo general partner and has grown into one of the largest funds run that way. Founded by Matt Cheng, who previously built two companies that each reached over $1 billion in public market value, the firm was designed from the start to invest across both the U.S. and Asia, backing early breakout companies in places like Croatia, Bangladesh, Japan, and Taiwan in addition to the U.S., with its Taipei roots still central to its identity alongside its Silicon Valley presence.